Noticias de Forex

Syros Pharmaceuticals To Acquire TYME Technologies

Syros Pharmaceuticals To Acquire TYME Technologies

Syros Pharmaceuticals (SYRS) and TYME Technologies, Inc. (TYME) announced that the companies have entered into a definitive merger agreement pursuant to which Syros will acquire TYME, including its pipeline assets and net cash at closing which after accounting for wind-down and transaction expenses is currently estimated to be approximately $60 million.
RTTNews | hace 702
DURECT Appoints Timothy Papp As New CFO

DURECT Appoints Timothy Papp As New CFO

Biopharmaceutical company DURECT Corp. (DRRX) announced Tuesday the appointment of Timothy Papp as its Chief Financial Officer. Papp brings over 25 years of corporate finance experience to DURECT, including 15 years in the Biopharma sector.
RTTNews | hace 702
Bay Street Likely To Open On Negative Note

Bay Street Likely To Open On Negative Note

Lower Canadian and U.S. futures, weakness in European markets and sluggish commodity prices point to a negative start for Canadian shares on Tuesday.
RTTNews | hace 702
more news
Titan Pharma Says FDA Clears IND Application For Nalmefene Implant

Titan Pharma Says FDA Clears IND Application For Nalmefene Implant

Titan Pharmaceuticals, Inc. (TTNP) announced Tuesday that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for a Phase 1 study of its six-month or longer subdermal formulation of nalmefene, an opioid antagonist, intended for the prevention of relapse following opioid detoxification in adults with Opioid Use Disorder (OUD).
RTTNews | hace 702
Vertex Pharma Says FDA Lifts Clinical Hold On Phase 1/2 Trial Of VX-880 To Treat Type 1 Diabetes

Vertex Pharma Says FDA Lifts Clinical Hold On Phase 1/2 Trial Of VX-880 To Treat Type 1 Diabetes

Vertex Pharmaceuticals Inc. (VRTX) announced Tuesday that the U.S. Food and Drug Administration (FDA) has lifted the clinical hold placed on the Phase 1/2 clinical trial of VX-880, an investigational stem cell-derived, fully differentiated pancreatic islet cell replacement therapy for people with type 1 diabetes (T1D) with impaired hypoglycemic awareness and severe hypoglycemia.
RTTNews | hace 702
UK Service Sector Growth Improves In June

UK Service Sector Growth Improves In June

UK service providers reported a faster growth in activity in June despite cost of living concerns and a weak economic outlook, final data from S&P Global showed on Tuesday. The headline S&P Global/Chartered Institute of Procurement & Supply final services Purchasing Managers' Index registered 54.3 in June, up slightly from 53.4 in May. The flash score was 53.4.
RTTNews | hace 702
Eurozone Private Sector Growth Weakens In June

Eurozone Private Sector Growth Weakens In June

The eurozone private sector expanded at a slower pace in June as the manufacturing production logged its first fall in two years on one side and the weaker growth in services activity on the other, final survey results from S&P Global showed on Tuesday. The final composite output index fell to 52.0 in June from 54.8 in the previous month. The reading was slightly above the initial estimate of 5
RTTNews | hace 702
Sensex, Nifty Give Up Early Gains

Sensex, Nifty Give Up Early Gains

Indian shares gave up early gains to end modestly lower on Tuesday after European markets opened lower on concerns over a possible global recession.
RTTNews | hace 702

Stay up to date!

Add Noticias to your browser

Extension Picture